company background image
000963 logo

Huadong Medicine SZSE:000963 Stock Report

Last Price

CN¥30.25

Market Cap

CN¥52.9b

7D

5.2%

1Y

-19.6%

Updated

16 Aug, 2024

Data

Company Financials +

Huadong Medicine Co., Ltd

SZSE:000963 Stock Report

Market Cap: CN¥52.9b

Huadong Medicine Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Huadong Medicine
Historical stock prices
Current Share PriceCN¥30.25
52 Week HighCN¥44.39
52 Week LowCN¥25.96
Beta0.59
11 Month Change6.78%
3 Month Change-9.02%
1 Year Change-19.61%
33 Year Change-20.21%
5 Year Change1.00%
Change since IPO675.14%

Recent News & Updates

Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Aug 05
Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

Jun 28
Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Jun 10
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Recent updates

Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Aug 05
Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

Jun 28
Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Jun 10
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Apr 08
Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Is Huadong Medicine (SZSE:000963) A Risky Investment?

Mar 16
Is Huadong Medicine (SZSE:000963) A Risky Investment?

Shareholder Returns

000963CN HealthcareCN Market
7D5.2%-1.4%-0.6%
1Y-19.6%-32.4%-19.0%

Return vs Industry: 000963 exceeded the CN Healthcare industry which returned -32.4% over the past year.

Return vs Market: 000963 matched the CN Market which returned -19% over the past year.

Price Volatility

Is 000963's price volatile compared to industry and market?
000963 volatility
000963 Average Weekly Movement4.3%
Healthcare Industry Average Movement4.7%
Market Average Movement5.6%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.7%

Stable Share Price: 000963 has not had significant price volatility in the past 3 months.

Volatility Over Time: 000963's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199316,969Liang Lvwww.eastchinapharm.com

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.

Huadong Medicine Co., Ltd Fundamentals Summary

How do Huadong Medicine's earnings and revenue compare to its market cap?
000963 fundamental statistics
Market capCN¥52.94b
Earnings (TTM)CN¥3.10b
Revenue (TTM)CN¥41.20b

17.1x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000963 income statement (TTM)
RevenueCN¥41.20b
Cost of RevenueCN¥27.66b
Gross ProfitCN¥13.55b
Other ExpensesCN¥10.44b
EarningsCN¥3.10b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.77
Gross Margin32.88%
Net Profit Margin7.53%
Debt/Equity Ratio9.7%

How did 000963 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

33%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.